Alector, Inc.

ALEC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017
Revenue $27.7M $3.7M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $73.0M $29.9M
SG&A Expense $11.9M $6.5M
Operating Income $-57.3M $-32.7M
Operating Margin -207.0% -874.9%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-52.2M $-32.5M
Net Margin -188.8% -869.6%
EPS (Basic) $-4.62 $-3.55
EPS (Diluted) $-4.62 $-3.55
Shares Outstanding (Basic) 13.8M
Shares Outstanding (Diluted) 13.8M
Dividends Per Share
← Newer Page 2 of 2 Older →